456 related articles for article (PubMed ID: 16227036)
1. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
2. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
3. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
4. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
5. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
[TBL] [Abstract][Full Text] [Related]
6. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
7. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
9. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for congenital adrenal hyperplasia in Wisconsin.
Allen DB
Wis Med J; 1993 Feb; 92(2):75-8. PubMed ID: 8451862
[TBL] [Abstract][Full Text] [Related]
13. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
[TBL] [Abstract][Full Text] [Related]
14. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
15. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
16. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
17. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
18. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
Brosnan CA; Brosnan P; Therrell BL; Slater CH; Swint JM; Annegers JF; Riley WJ
Public Health Rep; 1998; 113(2):170-8. PubMed ID: 9719819
[TBL] [Abstract][Full Text] [Related]
19. [Screening for congenital adrenal hyperplasia in Hungary].
Sólyom J
Orv Hetil; 1989 Sep; 130(37):1979-82, 1985-6. PubMed ID: 2780047
[TBL] [Abstract][Full Text] [Related]
20. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
